Total Brain Ltd (TTB)
20mins delayed
Movement
1 Year Return
Total Brain Ltd Chart
| Share price | |
| Last | |
| Change | |
| Volume | |
| Turnover | |
| Market Cap | $32.49 million |
| Today's Movement | |
| Prev. Close | |
| Open | |
| Day Range | - |
| VWAP | |
| Historical Stats | |
| 52w Range | - |
| 4w Avg Volume | |
| 4w Avg Turnover | |
| (delayed) | |
TTB Statistics
13 July
1,261 / 2,231
ASX Size Rank
1yr Return
vs Sector (1yr)
-8.77%
vs ASX 200 (1yr)
+21.85%
$32.49 million
Market Cap
Share Issue
108.3 million
All Ords (%)
N/A
Short Sold
0%
Current Fundamentals
13 July
N/A
PE Ratio
EPS ($)
-0.535
Earnings Yield
-178.33%
NTA ($)
1.00
N/A
Dividend Yield
DPS ($)
-
Gross Div. Yield
-
Gross DPS ($)
-
Company Overview
Total Brain Limited (TTB, formerly Brain Resource Limited) is developing and selling brain health products to consumers, corporates, clinicians and research. The Company currently provides two web products, Brain Training Platform and Clinical Decision Support, both of which are developed from the Company's platform, international Study to Predict Optimized Treatment (iSPOT). TTB has offices in San Francisco and Sydney and a global network of academics, scientists, researchers and universities.
Former Names
Brain Resource Company Limited (The), 07/05/2008; Brain Resource Limited (BRC), 30/11/2018
Upcoming Calendar
| 28 Aug 2020 | Report (Annual) |
| 28 Aug 2020 | Report (Prelim) |
| 23 Feb 2021 | Report (Interim) |
Dividend History
| Ex-Date | Amount | Franking | Type | Payable |
|---|---|---|---|---|
| No dividends paid in the last 5 years | ||||
See Upcoming Dividends for all ASX companies.
Announcements
| Date | Heading | Pages | File Size | Time |
|---|---|---|---|---|
Broker Consensus
The buy, hold and sell recommendations from Australian stockbroking firms are combined to form a "broker consensus". See the Consensus Data posts for more information.
TTB is not covered by a major broker,
or data from most recent compilation was omitted due
to not meeting QA guidelines.
Directors & Management
| Name | Title | Since | Bio |
|---|---|---|---|
| Dr Evian Gordon | Executive Chairman, Executive Director | Aug 2000 |
|
| Mr Matthew (Matt) Morgan | Non-Executive Director | Mar 2016 |
|
| Mr Louis Gagnon | Chief Executive Officer, Managing Director | May 2017 |
|
| Mr David Torrible | Non-Executive Director | Jun 2019 |
|
| Mr David Daglio | Non-Executive Director | Jan 2020 |
|
| Mr Nathan Jong | Joint Company Secretary | Nov 2019 | |
| Mr Phillip Hains | Joint Company Secretary | Jul 2018 | |
| Mr Matthew Mund | Chief Operating Officer | N/A | |
| Mr Emil Vasilev | Director of Finance and Operations | N/A |
Director Transactions
TTB directors must report any change in shareholding to the ASX within 5 business days.
See Director Transactions for all ASX companies.
| Date | Director | Type | Amount | Price | Value | Notes |
|---|---|---|---|---|---|---|
| 16/01/20 | David Torrible | Issued | 29,126,903 | $0.046 | $1,339,837 | Issue of securities. |
| 16/01/20 | David Torrible | Issued | 2,066,115 | $0.830 | $1,714,875 | Issue of options. |
| 22/11/19 | Ajay Arora | Issued | 1,920,810 | $0.105 | $201,685 | Issue of options. |
| 16/05/19 | Matthew (Matt) Morgan | Buy | +296,429 | $0.028 | $8,300 | Off-market trade. |
| 12/02/19 | Matthew (Matt) Morgan | Buy | +315,111 | $0.027 | $8,557 | On-market trade. |
| 19/12/18 | Matthew (Matt) Morgan | Buy | +284,320 | $0.030 | $8,529 | On-market trade. |
| 16/11/18 | Matthew (Matt) Morgan | Buy | +134,219 | $0.035 | $4,697 | On-market trade. |
| 04/06/18 | Louis Gagnon | Buy | +2,035,000 | $0.040 | $80,475 | Off-market trade. |
| 14/03/18 | Matthew (Matt) Morgan | Buy | +175,675 | $0.050 | $8,814 | On-market trade. |
| 10/01/18 | Matthew (Matt) Morgan | Issued | 4,000,000 | $0.062 | $248,000 | Issue of options. |
| 10/01/18 | Louis Gagnon | Issued | 56,465,912 | $0.062 | $3,500,886 | Issue of options. |
Shareholder Distribution
| Holding Size | 1 - 1,000 | 1,001 - 5,000 | 5,001 - 10,000 | 10,001 - 100,000 | 100,001 and over | Total Shareholders |
|---|---|---|---|---|---|---|
| No. of Shareholders | 24 | 9 | 56 | 242 | 320 | 651 |
Top 20 Shareholders
| Name | Shares | Capital |
|---|---|---|
| Citicorp Nominees Pty Limited | 213,373,445 | 27.44% |
| Cs Third Nominees Pty Limited (Hsbc Cust Nom Au Ltd 13 A/C) | 50,625,000 | 6.51% |
| Stuttgart Pty Ltd | 39,000,001 | 5.01% |
| Morgan Stanley Australia Securities (Nominee) Pty Ltd (No 1 Account) | 36,513,319 | 4.70% |
| HSBC Custody Nominees (Australia) Limited | 33,171,748 | 4.27% |
| Invia Custodian Pty Limited (Torrible Super Fund A/C) | 25,573,111 | 3.29% |
| Bnp Paribas Nominees Pty Ltd (Ib Au Noms Retailclient Drp) | 22,180,978 | 2.85% |
| Garrett Walker | 12,575,452 | 1.62% |
| J P Morgan Nominees Australia Pty Limited | 11,568,277 | 1.49% |
| Dr Evian Gordon | 11,240,248 | 1.45% |
| Gleneagle Securities (Aust) Pty Ltd | 11,000,000 | 1.41% |
| Dbpc Group Finance Pty Ltd (Dbpc Group Finance A/C) | 10,250,000 | 1.32% |
| HSBC Custody Nominees (Australia) Limited A/C 2 | 9,196,393 | 1.18% |
| Ceyx Holdings Pty Ltd | 9,000,000 | 1.16% |
| Coleman Fung | 7,154,406 | 0.92% |
| Mr Tim Yates | 7,154,406 | 0.92% |
| Spinite Pty Ltd | 6,655,429 | 0.86% |
| Baxter Manor Pty Ltd | 6,517,545 | 0.84% |
| UBS Nominees Pty Ltd | 5,900,000 | 0.76% |
| Invia Custodian Pty Limited (Torrible Family A/C) | 5,852,635 | 0.75% |
| All other shareholders | 31.25 % | |
The Top 20 Shareholders of TTB hold 68.75% of shares on issue.
TTB Share Price History
| Date | Close | Change | % Change | Open | High | Low | Volume | Turnover |
|---|---|---|---|---|---|---|---|---|
TTB Historical Data
Download up to 20 years of share price history.
| Year | Closing Price (30 June) | Last Trade |
|---|---|---|
| 2019 | $0.026 | 28 June |
Offical data as published by ASX. See more Data Downloads.
Company Details
Principal Activity: Developing and selling brain health products.
Incorporated: in NSW on 08/08/2000. Name changed to Brain Resource Limited on 07/05/2008.
15 Belvoir St
Surry Hills NSW 2010
All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.